Tumor shrinkage assessed by volumetric MRI in long-term follow-up after fractionated stereotactic radiotherapy of nonfunctioning pituitary adenoma and fractionated stereotactic radiotherapy in the treatment of pituitary adenomas
- Weitere Titel
-
Tumorremission bewertet mittels volumetrischer MRT im Langzeitverlauf nach fraktionierter stereotaktischer Strahlentherapie von nicht-funktionellen Hypophysenadenomen und Fraktionierte stereotaktische Strahlentherapie in der Behandlung von Hypophysenadenomen
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
München, Technische Universität München, Dissertation, 2024
- Schlagwort
-
Kernspintomografie
Strahlentherapie
- Ereignis
-
Veröffentlichung
- (wo)
-
München
- (wer)
-
Universitätsbibliothek der TU München
- (wann)
-
2024
- Urheber
-
Poullos, Nektarios
- Beteiligte Personen und Organisationen
- URN
-
urn:nbn:de:bvb:91-diss-20240718-1506647-1-0
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:52 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Poullos, Nektarios
- Molls, Michael
- Combs, Stephanie E.
- Universitätsbibliothek der TU München
Entstanden
- 2024
Ähnliche Objekte (12)
Volumetric Regression in Brain Metastases After Stereotactic Radiotherapy: Time Course, Predictors, and Significance
Volumetric Regression in Brain Metastases After Stereotactic Radiotherapy: Time Course, Predictors, and Significance
Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases: a pooled analysis of the German working group "stereotactic radiotherapy"
Quality requirements for MRI simulation in cranial stereotactic radiotherapy: a guideline from the German Taskforce "Imaging in Stereotactic Radiotherapy"
Transient Enlargement in Meningiomas Treated with Stereotactic Radiotherapy
Transient Enlargement in Meningiomas Treated with Stereotactic Radiotherapy
Stereotactic body radiotherapy (SBRT) for pulmonary metastases from renal cell carcinoma: a multicenter analysis of the German working group “Stereotactic Radiotherapy”
Dose prescription for stereotactic body radiotherapy: general and organ-specific consensus statement from the DEGRO/DGMP Working Group Stereotactic Radiotherapy and Radiosurgery
Efficacy of stereotactic body radiotherapy in patients with hepatocellular carcinoma not suitable for transarterial chemoembolization (HERACLES: HEpatocellular Carcinoma Stereotactic RAdiotherapy CLinical Efficacy Study)
Stereotactic body radiotherapy of adrenal metastases - a dose‐finding study
Systemic immune modulation by stereotactic radiotherapy in early-stage lung cancer
Sparing the hippocampus and the hypothalamic- pituitary region during whole brain radiotherapy: a volumetric modulated arc therapy planning study
Volumetric Regression in Brain Metastases After Stereotactic Radiotherapy: Time Course, Predictors, and Significance
Volumetric Regression in Brain Metastases After Stereotactic Radiotherapy: Time Course, Predictors, and Significance
Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases: a pooled analysis of the German working group "stereotactic radiotherapy"
Quality requirements for MRI simulation in cranial stereotactic radiotherapy: a guideline from the German Taskforce "Imaging in Stereotactic Radiotherapy"
Transient Enlargement in Meningiomas Treated with Stereotactic Radiotherapy
Transient Enlargement in Meningiomas Treated with Stereotactic Radiotherapy
Stereotactic body radiotherapy (SBRT) for pulmonary metastases from renal cell carcinoma: a multicenter analysis of the German working group “Stereotactic Radiotherapy”
Dose prescription for stereotactic body radiotherapy: general and organ-specific consensus statement from the DEGRO/DGMP Working Group Stereotactic Radiotherapy and Radiosurgery
Efficacy of stereotactic body radiotherapy in patients with hepatocellular carcinoma not suitable for transarterial chemoembolization (HERACLES: HEpatocellular Carcinoma Stereotactic RAdiotherapy CLinical Efficacy Study)
Stereotactic body radiotherapy of adrenal metastases - a dose‐finding study
Systemic immune modulation by stereotactic radiotherapy in early-stage lung cancer
Sparing the hippocampus and the hypothalamic- pituitary region during whole brain radiotherapy: a volumetric modulated arc therapy planning study
Volumetric Regression in Brain Metastases After Stereotactic Radiotherapy: Time Course, Predictors, and Significance
Volumetric Regression in Brain Metastases After Stereotactic Radiotherapy: Time Course, Predictors, and Significance
Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases: a pooled analysis of the German working group "stereotactic radiotherapy"
Quality requirements for MRI simulation in cranial stereotactic radiotherapy: a guideline from the German Taskforce "Imaging in Stereotactic Radiotherapy"
Transient Enlargement in Meningiomas Treated with Stereotactic Radiotherapy
Transient Enlargement in Meningiomas Treated with Stereotactic Radiotherapy
Stereotactic body radiotherapy (SBRT) for pulmonary metastases from renal cell carcinoma: a multicenter analysis of the German working group “Stereotactic Radiotherapy”
Dose prescription for stereotactic body radiotherapy: general and organ-specific consensus statement from the DEGRO/DGMP Working Group Stereotactic Radiotherapy and Radiosurgery
Efficacy of stereotactic body radiotherapy in patients with hepatocellular carcinoma not suitable for transarterial chemoembolization (HERACLES: HEpatocellular Carcinoma Stereotactic RAdiotherapy CLinical Efficacy Study)
Stereotactic body radiotherapy of adrenal metastases - a dose‐finding study
Systemic immune modulation by stereotactic radiotherapy in early-stage lung cancer